Development of new strategies for early diagnosis of mucormycosis from bench to bedside

Early diagnosis and initiation of amphotericin B (AmB) for treatment of mucormycosis increases survival from approximately 40% to 80%. The central objective of a new study of the European Confederation of Medical Mycology (ECMM) and the International Society for Human and Animal Mycology (ISHAM) Zyg...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Mycoses
Prif Awduron: Walsh, Thomas J., Skiada, Anna, Cornely, Oliver A., Roilides, Emmanuel, Ibrahim, Ashraf, Zaoutis, Theoklis, Groll, Andreas, Lortholary, Olivier, Kontoyiannis, Dimitrios P., Petrikkos, George
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4464811/
https://ncbi.nlm.nih.gov/pubmed/25475924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/myc.12249
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg